Investors now choose among over a dozen spot Bitcoin ETFs, including iShares and Morgan Stanley funds, amid rising copycat products in the ETF market. The U.S. ETF market now includes nearly 5,300 exchange-traded products, with spot Bitcoin ETFs emerging as a rapidly growi
Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro surged again. The pharmaceutical giant now expects 20
Bloomin' Brands press release (BLMN): Q2 Non-GAAP EPS of $0.39 beats by $0.10. - Revenue of $1.02B (+2.0% Y/Y) beats by $20M. - Fiscal 2026 Financial OutlookThe table below presents our updated expectations for selected 2026 financial operating results. We are reaffirming
Freshpet press release (FRPT): Q2 GAAP EPS of $0.39 beats by $0.17. - Revenue of $305.6M (+15.5% Y/Y) beats by $13.44M. - Outlook For full year 2026, the Company is updating its guidance and now expects the following: - Net sales growth in Outlook For full year 2026, the Company...</stron
Delek US press release (DK): Q2 Non-GAAP EPS of $5.48 beats by $2.84. - Revenue of $4.08B (+47.8% Y/Y) beats by $490M. - Delek Logistics (DKL) ("DKL") had its best quarter reporting adjusted EBITDA of $143.5 million. It is well positioned to meet its annual EBITDA guidance
Perrigo press release (PRGO): Q2 Non-GAAP EPS of $0.50 beats by $0.15. - Revenue of $1.02B (-3.8% Y/Y) beats by $10M. - Core adjusted gross margin decreased 250 basis points to 37.0%. - Outlook: The Company continues to closely monitor the consumer and macroeconomic
August 5 What matters in U.S. and global markets today By Mike Dolan, Editor-at-Large, Finance and Markets For all the doubts and handwringing, the S&P 500 and Dow Jones are back at record highs after surging on Tuesday amid falling oil prices and the bumper earnings season.
Walt Disney press release (DIS): Q3 Non-GAAP EPS of $2.06 beats by $0.21. - Revenue of $25.25B (+6.8% Y/Y) misses by $160M. - Fiscal 2026 outlook:â¢We continue to expect fiscal 2026 adjusted EPS growth of approximately 12%, excluding the impact of the
Thomson Reuters press release (TRI): Q2 Non-GAAP EPS of $0.99 beats by $0.03. - Revenue of $1.95B (+9.6% Y/Y) beats by $30M. - Total company revenues up 9% / organic revenues up 8% - Organic revenues up 10% for the "Big 3" segments (Legal Professionals, Corporates and Tax, Audit...</stron
By Shashwat Chauhan and Kanchana Chakravarty August 5 Investors are pouring money into U.S. healthcare stocks, betting that improving earnings, rising dealmaking and attractive valuations will extend the sector's rebound after years of underperformance. The renewed appetit
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.